Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersOphthalmology Physician in Layton, UT
NPI: 1184923807Primary Practice Location
HOLY CROSS HOSPITAL-DAVIS
1600 W Antelope Dr, Layton, UT
Primary Employer
Tanner Memorial Clinic
tannerclinic.com
HQ Phone
Get M.D. Trent's Phone NumberMobile
Get M.D. Trent's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardUT State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 261 | 292 |
| 2 | 92012Eye and medical examination for diagnosis and treatment, established patient | 168 | 249 |
| 3 | 92004Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | 152 | 152 |
| 4 | 92250Photography of the retina | 118 | 119 |
| 5 | 92134Diagnostic imaging of retina | 89 | 106 |
Cerebrovasospasm following endoscopic cerebrospinal fluid leak repair.
Authors: Jason Hunt
Journal: Skull Base
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Lifitegrast 5% Ophthalmic Solution, DRUG: SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate), DRUG: Mycophenolic Acid 0.1%, DRUG: Mycophenolic Acid 0.3%, DRUG: Betamethasone Sodium Phosphate 0.01%, DRUG: Placebo Comparator: Vehicle, DRUG: Cyclosporine 0.05% Ophthalmic Emulsion
Lead Sponsor: Kala Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Vehicle of KPI-121 0.25% Ophthalmic Suspension, DRUG: KPI-121 0.25% Ophthalmic Suspension
